Hematology-Oncology Clinics of North America

Papers
(The median citation count of Hematology-Oncology Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Prognostic and Predictive Implications of Cytogenetics and Genomics116
Autoimmune Hemolytic Anemia: An Old Disease with New Twists62
Managing First-Line Metastatic Renal Cell Carcinoma54
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver53
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia35
Conflict and Access to Health Care35
Insights into Renal Cell Carcinoma with Novel Imaging Approaches33
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia29
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis28
Cancer of the Larynx and Hypopharynx28
Treatment of High-Risk Gestational Trophoblastic Neoplasia28
Contents27
Contributors26
Benefits and Harms of Interception and Early Detection of Cancer25
Hematology/Oncology Clinics of North America25
Copyright23
Contributors23
Future Directions for Gestational Trophoblastic Disease22
Updates in the Management of Warm Autoimmune Hemolytic Anemia21
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer21
The Evolving Landscape of Drug Therapies for Sickle Cell Disease20
Factor XIII Deficiency20
Advances in Gastric Cancer Surgical Management19
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes18
Advances in Immunotherapy in Esophagogastric Cancer17
Disparities in Breast Cancer Outcomes and How to Resolve Them17
Forthcoming Issues16
Inherited Platelet Disorders14
Emerging Therapies in β-Thalassemia14
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas14
Advances in Surgical Techniques for Lung Cancer14
Genomic Alterations in Langerhans Cell Histiocytosis13
Contents13
Foreword13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes13
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma13
Histiocytic Disorders in Pediatric and Adult Patients13
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia13
Advances in Systemic Therapy in Pancreatic Cancer13
Adult Evans' Syndrome12
Forthcoming Issues12
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia12
Liposarcoma12
Red Cell Antigens and Antibodies12
Copyright11
Genomics of Resistance to Targeted Therapies11
New Developments in Myeloma11
Clinical Vignettes Part I11
Evaluation and Management of Bing–Neel Syndrome11
Hereditary Renal Cell Carcinoma Syndromes11
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors11
Genes as Medicine11
Skin Cancer Precursors11
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities10
Gestational Trophoblastic Neoplasia10
Malignancies of the Upper Gastrointestinal Tract10
Contents10
Heavy Ion Particle Therapy in Modern Day Radiation Oncology9
Patient-Reported Outcomes in Radiation Oncology9
Copyright9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy9
High-Risk Non-Melanoma Skin Cancers9
Local Control in Soft Tissue Sarcomas9
Advances in the Surgical Management of Esophageal Cancer8
Melanoma Brain Metastasis8
Forthcoming Issues8
Bispecific Antibodies in the Treatment of Multiple Myeloma8
Contents8
Evolution of Gene Therapy, Historical Perspective8
Copyright8
Disparities and Inequities Among Patients with Central Nervous System Tumor8
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma7
Radiation-Induced Tissue Regeneration7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer7
Breast Cancer and Lifestyle Factors7
Contents7
Breast Cancer in India7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms7
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma6
Copyright6
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors6
Chronic Lymphocytic Leukemia6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies6
Targeted Therapy Innovations for Melanoma5
Impact of Clonal Heterogeneity in Multiple Myeloma5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy5
Ductal Carcinoma In Situ5
Genetics and Genomics of Gestational Trophoblastic Disease5
Contributors5
Pathogenic Mechanisms in Thalassemia II5
Pathogenic Mechanisms in Thalassemia I5
Early Detection of Precursor Diseases of Multiple Myeloma5
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors5
FLASH Radiotherapy5
Clinical Complications and Their Management5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma5
Immune-Pathogenesis of Myeloma5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing5
Disorders of Fibrinogen and Fibrinolysis5
Education and Training Models for Remote Learning5
Hemophilia A/B5
Contents5
Merkel Cell Carcinoma5
Sarcomas5
Copyright5
Contributors4
Forthcoming Issues4
Renal Cell Cancer4
Approach to High-Risk Multiple Myeloma4
Local Therapies in Advanced Colorectal Cancer4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)4
Regulatory Aspects of Gene Therapy4
Waldenström Macroglobulinemia4
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia4
Contributors4
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia4
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors4
Role of Radiation in Treatment of Renal Cell Carcinoma4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia4
Contents4
Immunotherapy-associated Autoimmune Hemolytic Anemia4
Remembering the Contributions of Professor David J. Weatherall4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings4
Complications of Autoimmune Hemolytic Anemia4
Copyright3
New Therapies on the Horizon3
Robotic and Endoscopic Approaches to Head and Neck Surgery3
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia3
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)3
Contributors3
Gastrointestinal Cancer Precursor Conditions and Their Detection3
Surgical Management of Neuroendocrine Tumor Liver Metastases3
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia3
Preface3
Smoldering Multiple Myeloma3
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?3
Hereditary Colorectal Cancer3
Forthcoming Issues3
Colorectal Cancer in Younger Adults3
Contents3
Contents3
Contents3
Debate3
Copyright3
Functional Radiosurgery in the Management of Cancer Pain3
Contents3
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer3
Cancer of the Paranasal Sinuses3
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast Cancer3
Contributors3
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma3
Immunotherapy for Head and Neck Cancer3
First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer3
Biology and Treatment of Meningiomas3
Contributors3
Role of Ovarian Suppression in Early Premenopausal Breast Cancer3
Preface3
Breast Cancer Pathology in the Era of Genomics3
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity3
Cutaneous T-cell Lymphoma3
Innovation and Emerging Technologies in Radiation Oncology3
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals3
Immunotherapy2
Impact of Social Media on Oncology Care2
Radiotherapy for Pancreatic Adenocarcinoma2
Evidence-Based Guidance for Breast Cancer Survivorship2
Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases2
Forthcoming Issues2
Novel Targeted Therapies for Renal Cell Carcinoma2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma2
Role of Surgery in Metastatic Renal Cell Carcinoma2
Copyright2
Hematopoietic Stem Cell Transplantation in Thalassemia2
Contributors2
Advances and Opportunities in the Management of Lung Cancer2
Patient, Caregiver, and Provider Well-Being in Oncology2
Contributors2
Contents2
Factor XI Deficiency2
Copyright2
Artificial Intelligence, Machine Learning and Big Data in Radiation Oncology2
The Role of the Pathologist in Renal Cell Carcinoma Management2
Gene Therapy for Inborn Errors of Immunity2
Surgical Management of Colorectal Cancer Liver Metastases2
Neurofibromatoses2
Copyright2
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges Ahead2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer2
Forthcoming Issues2
Surgical Management of Gestational Trophoblastic Neoplasia2
The Emerging Potential of Lead-212 Theranostics2
Contributors2
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer2
Macrophage Activation Syndrome2
Colorectal Cancer: Advancing Science, Improving Access, and Refining Therapy2
The Gut Microbiome in Colorectal Cancer2
Locally Advanced Lung Cancer2
Surgical Management of Genitourinary Cancer Liver Metastases2
Lip and Oral Cavity Squamous Cell Carcinoma2
Novel Immune Therapies for Renal Cell Carcinoma2
Microbiome and Immunotherapy for Melanoma2
Cervical Cancer2
Evolving Concepts in the Management of Desmoid Tumors2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer2
Contents2
Emerging Role of Blood-based Biomarkers in Sarcomas2
Forthcoming Issues2
Forthcoming Issues2
DAT-Negative Autoimmune Hemolytic Anemia1
Hemophilia B (Factor IX Deficiency)1
Contents1
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?1
Copyright1
Forthcoming Issues1
Pathology of Gestational Trophoblastic Disease (GTD)1
Contributors1
Gastrointestinal Stromal Tumor1
What Is New in Small Cell Lung Cancer1
Is There a Role for Immunotherapy in Central Nervous System Cancers?1
Cereblon-Targeting Ligase Degraders in Myeloma1
Clinical Vignettes, Part II: Eyes, Teeth, and Bone1
Ultra High-risk Gestational Trophoblastic Neoplasia1
Quality of Life in Sickle Cell Disease1
External Beam Radiation Therapy for Liver Metastases1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease1
Role of Consolidation and Maintenance1
Sickle Cell Disease: New Approaches for an Old Disease1
Smart Solutions to Address the Global Gap in Radiation Oncology Through Trainee Engagement and Partnerships with Industry1
Surgical Management of the Axilla for Breast Cancer1
Chimeric Antigen Receptor T-cell Therapy1
Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?1
Triplet Therapies in Chronic Lymphocytic Leukemia1
Lung Cancer Supportive Care and Symptom Management1
Managing Recurrent Metastatic Head and Neck Cancer1
Copyright1
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care1
Contents1
Lung Cancer1
Gene-Based Therapies for Pediatric Blood Diseases1
Resistance to Bruton Tyrosine Kinase Inhibitors1
Leptomeningeal Disease1
Central Nervous System Complications Among Oncology Patients1
Contributors1
Proteasome Inhibitors in Multiple Myeloma1
Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond1
0.077416181564331